Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.73 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 4/20 | 0.63 |
| ▸ | RAB9A | P51151 | 4/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | EGFR | P00533 | 1/20 | 0.52 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL710645 | 0.97 | BCHE (0.69) | BCHEGAANPC1RAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL710646 | 0.97 | BCHE (0.69) | BCHEGAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17200183 | 0.94 | BCHE (0.65) | BCHEGAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL370724 | 0.91 | BCHE (0.86) | BCHEGAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29550341 | 0.91 | BCHE (0.86) | BCHEGAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29356647 | 0.90 | BCHE (0.69) | BCHEGAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4963924 | 0.90 | BCHE (0.69) | BCHEGAANPC1RAB9ASMN1; SMN2 | |
| Magnesium SCHEMBL30119882 | 0.90 | BCHE (0.83) | BCHEGAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL20677810 | 0.86 | BCHE (0.77) | BCHEGAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5609299 | 0.85 | BCHE (0.75) | BCHEGAANPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250083109-A1 | Polymeric Composites Having Oriented Nanopores and Methods of Making the Same | UNIV YALE (US) | 2025-03-13 | — | — | US | disclosed |
| EP-3676269-A1 | NEW ANIONIC SURFACTANTS AND DETERGENTS AND CLEANING AGENTS CONTAINING SAME | Henkel AG & Co. KGaA (DE) | 2020-07-08 | — | — | EP | disclosed |
| EP-3676258-A1 | NEW ANIONIC SURFACTANTS AND DETERGENTS AND CLEANING AGENTS CONTAINING SAME | Henkel AG & Co. KGaA (DE) | 2020-07-08 | — | — | EP | disclosed |
| EP-3625318-A1 | COLOR-PROTECTING DETERGENTS | Henkel AG & Co. KGaA (DE) | 2020-03-25 | — | — | EP | disclosed |
| EP-3497193-A1 | DETERGENTS AND CLEANING AGENTS HAVING ANIONIC SURFACTANTS CONSISTING OF RENEWABLE RAW MATERIALS | Henkel AG & Co. KGaA (DE) | 2019-06-19 | — | — | EP | disclosed |
| EP-3497194-A1 | NEW ANIONIC SURFACTANTS AND DETERGENTS AND CLEANING AGENTS CONTAINING SAME | Henkel AG & Co. KGaA (DE) | 2019-06-19 | — | — | EP | disclosed |
| US-20190030490-A1 | Polymeric Composites Having Oriented Nanopores and Methods of Making the Same | UNIV YALE (US) | 2019-01-31 | — | — | US | disclosed |
| EP-1603957-B1 | POLYMERISATION AND OLIGOMERISATION CATALYSTS | INEOS SALES UK LTD (GB) | 2015-10-28 | — | — | EP | disclosed |
| EP-1603957-B1 | POLYMERISATION AND OLIGOMERISATION CATALYSTS | INEOS SALES UK LTD (GB) | 2015-10-28 | — | — | EP | disclosed |
| US-8124698-B2 | Diene polymerisation | INEOS EUROPE LIMITED (GB) | 2012-02-28 | — | — | US | disclosed |
| US-20100022724-A1 | Diene Polymerisation | INEOS SALES (UK) LIMITED (GB) | 2010-01-28 | — | — | US | disclosed |
| US-7229943-B2 | Polymerisation and oligomerisation catalysts | INNOVENE EUROPE LIMITED (GB) | 2007-06-12 | — | — | US | disclosed |
| US-7229943-B2 | Polymerisation and oligomerisation catalysts | INNOVENE EUROPE LIMITED (GB) | 2007-06-12 | — | — | US | disclosed |
| US-7229943-B2 | Polymerisation and oligomerisation catalysts | INNOVENE EUROPE LIMITED (GB) | 2007-06-12 | — | — | US | disclosed |
| US-20060094588-A1 | Polymerisation and oligomerisation catalysts | BARCLAYS BANK PLC (GB) | 2006-05-04 | — | — | US | disclosed |
| EP-1603957-A1 | POLYMERISATION AND OLIGOMERISATION CATALYSTS | Innovene Europe Limited (GB) | 2005-12-14 | — | — | EP | disclosed |
| WO-2004083263-A1 | POLYMERISATION AND OLIGOMERISATION CATALYSTS | INNOVENE EUROPE LIMITED (GB) | 2004-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094588-A1 | Polymerisation and oligomerisation catalysts | CCNA1, AP2M1, AP2A1 | BCHE 4523/4885GAA 1915/4885NPC1 2996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.